ZaiboLiMD

Pathology • Columbus, OH

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Li's full profile

Already have an account?

Office
410 W 10th Ave
E403 Doan Hall
Columbus, OH 43210
Phone+1 614-293-5905

Fax+1 614-293-4715

Education & Training

UPMC Medical Education (Presbyterian Shadyside Hospital) AFellowship, Selective Pathology, 2013 - 2014
UPMC Medical EducationFellowship, Cytopathology, 2012 - 2013
UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 2008 - 2012
Beijing Medical UniversityClass of 1995

Certifications & Licensure

OH State Medical License 2014 - 2026
PA State Medical License 2008 - 2014
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry.
Maryam Tahir, Deyin Xing, Qingqing Ding, Yihong Wang, Kamaljeet Singh
Histopathology. 2025-01-01
2 citations
Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges.
Marie Brevet, Zaibo Li, Anil Parwani
Journal of Pathology Informatics. 2024-12-01
Clinicopathologic Characteristics and Follow-Up Outcomes of Invasive Breast Carcinoma With Different Positive HER2 Fluorescence In Situ Hybridization Patterns: Experie...
Zaibo Li, Yan Hu, Dan Jones, Weiqiang Zhao, Gary Tozbikian
Modern Pathology. 2024-10-26

Journal Articles

Identification of HER2 Immunohistochemistry-Negative, FISH-Amplified Breast Cancers and Their Response to Anti-HER2 Neoadjuvant Chemotherapy
Zaibo Li, Anil V Parwani, Gary Tozbikian, American Journal of Clinical Pathology

Press Mentions

A Solitary Brain Metastasis as the Only Site of Recurrence of HR Positive, HER2 Negative Breast Cancer: A Case Report and Review of the LiteratureJanuary 7th, 2021